Abranilla, Baby Girl .
HRN: 26-63-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2025
AMPICILLIN 250MG (VIAL)
01/30/2025
02/06/2025
IV
35mg
Q 12
PSNB
Waiting Final Action
01/30/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/30/2025
02/06/2025
IV
9 Mg
Q 24
PSNB
Waiting Final Action
02/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/20/2025
02/27/2025
IV
7.5mg
Q8
PSNB
Waiting Final Action
02/20/2025
MUPIROCIN 2%, 15G (TUBE)
02/20/2025
02/27/2025
TOPICAL
15g
TID
Phlebitis
Waiting Final Action